Publications by authors named "Danielle M Shea"

Claim this Profile
P
Prevalence of Kaposi's sarcoma-associated herpesvirus and transfusion-transmissible infections in Tanzanian blood donors.
Salum J Lidenge, Tara Tran, For Yue Tso, John R Ngowi, Danielle M Shea

Int J Infect Dis· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Viral and Immunological Analytes are Poor Predictors of the Clinical Treatment Response in Kaposi's Sarcoma Patients.
Salum J Lidenge, For Yue Tso, Yasaman Mortazavi, John R Ngowi, Danielle M Shea

Cancers (Basel)· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Similar Immunological Profiles Between African Endemic and Human Immunodeficiency Virus Type 1-Associated Epidemic Kaposi Sarcoma (KS) Patients Reveal the Primary Role of KS-Associated Herpesvirus in KS Pathogenesis.
Salum J Lidenge, For Yue Tso, Owen Ngalamika, John R Ngowi, Yasaman Mortazavi, Danielle M Shea

J Infect Dis· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Higher levels of neutralizing antibodies against KSHV in KS patients compared to asymptomatic individuals from Zambia.
Pankaj Kumar, Nithal Y Kuwa, Veenu Minhas, Clemence Marimo, Danielle M Shea

PLoS One· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early childhood infection of Kaposi's sarcoma-associated herpesvirus in Zambian households: a molecular analysis.
Landon N Olp, Danielle M Shea, Maxine K White, Clement Gondwe, Chipepo Kankasa

Int J Cancer· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The human immunodeficiency virus type 1 envelope confers higher rates of replicative fitness to perinatally transmitted viruses than to nontransmitted viruses.
Xiaohong Kong, John T West, Hong Zhang, Danielle M Shea, Tendai J M'soka

J Virol· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variants of human immunodeficiency virus type 1 that efficiently use CCR5 lacking the tyrosine-sulfated amino terminus have adaptive mutations in gp120, including loss of a functional N-glycan.
Emily J Platt, Danielle M Shea, Patrick P Rose, David Kabat

J Virol· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis